Chinese Investors Wary Of In-Licensing-Only Biotechs After IPO Setback

 
• By Dexter Jie Yan
  
red flag raised for Chinese investors
Chinese exchange’s refusal of one biotech’s IPO request raises red flag to some investors. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia